|
1
|
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$5.58M
|
+$1.13M
|
+137,401
|
+26%
|
|
|
2
|
Gilead Sciences
Foster City,
California
|
$5.47M
|
–
|
–
|
–
|
|
|
3
|
Frazier Life Sciences Management
Palo Alto,
California
|
$3.55M
|
-$16
|
-2
|
-0%
|
|
|
4
|
Sio Capital Management
New York
|
$1.28M
|
-$25
|
-3
|
-0%
|
|
|
5
|
Vanguard Capital Management
Malvern,
Pennsylvania
|
$1.04M
|
+$1.01M
|
+123,660
|
New
|
|
|
6
|
Caligan Partners
New York
|
$943K
|
+$918K
|
+112,128
|
New
|
|
|
7
|
Merck & Co
Rahway,
New Jersey
|
$891K
|
-$8
|
-1
|
-0%
|
|
|
8
|
Stonepine Capital Management
Bend,
Oregon
|
$540K
|
+$452K
|
+55,143
|
+611%
|
|
|
9
|
|
$484K
|
-$20.4K
|
-2,496
|
-4%
|
|
|
10
|
Renaissance Technologies
New York
|
$417K
|
+$204K
|
+24,965
|
+101%
|
|
|
11
|
AJU IB Investment Company
Seoul,
South Korea
|
$401K
|
-$8
|
-1
|
-0%
|
|
|
12
|
Geode Capital Management
Boston,
Massachusetts
|
$313K
|
+$112K
|
+13,699
|
+58%
|
|
|
13
|
Fidelity Investments
Boston,
Massachusetts
|
$307K
|
-$8
|
-1
|
-0%
|
|
|
14
|
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
|
$239K
|
+$233K
|
+28,475
|
New
|
|
|
15
|
GSA Capital Partners
London,
United Kingdom
|
$143K
|
+$52.2K
|
+6,377
|
+60%
|
|
|
16
|
Velan Capital Investment Management
Alpharetta,
Georgia
|
$120K
|
+$17.5K
|
+2,142
|
+18%
|
|
|
17
|
Ghisallo Capital Management
Boston,
Massachusetts
|
$116K
|
-$538K
|
-65,716
|
-83%
|
|
|
18
|
State Street
Boston,
Massachusetts
|
$112K
|
-$25
|
-3
|
-0%
|
|
|
19
|
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
$35.4K
|
+$34.4K
|
+4,206
|
New
|
|
|
20
|
UBS Group
Zurich,
Switzerland
|
$34K
|
+$32.9K
|
+4,023
|
+26,820%
|
|
|
21
|
|
$1.98K
|
+$1.97K
|
+240
|
New
|
|
|
22
|
Vanguard Global Advisers
Malvern,
Pennsylvania
|
$1.77K
|
+$1.72K
|
+210
|
New
|
|
|
23
|
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$1K
|
+$745
|
+91
|
New
|
|
|
24
|
Key Financial Inc
West Chester,
Pennsylvania
|
$496
|
–
|
–
|
–
|
|
|
25
|
Point72 Asset Management
Stamford,
Connecticut
|
–
|
-$2.56M
|
-285,714
|
Closed
|
|
